Estimating the Prevalence of Anxiety and Mood Disorders in an Adolescent General Population: An Evaluation of the GHQ12

ISSN： 1557-1874

Source： International Journal of Mental Health and Addiction, Vol.9, Iss.4, 2011-08, pp. : 410-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Riluzole in the Treatment of Mood and Anxiety Disorders

By Pittenger Christopher Coric Vladimir Banasr Mounira

CNS Drugs, Vol. 22, Iss. 9, 2008-01 ,pp. : 761-786

Adis International

Access to resources Recommend Favorite

Anxiety and Mood Disorders and Cannabis Use

By Cheung Joyce T. W. Mann Robert E. Ialomiteanu Anca Stoduto Gina Chan Vincy Ala-Leppilampi Kari Rehm Jürgen

The American Journal of Drug and Alcohol Abuse, Vol. 36, Iss. 2, 2010-03 ,pp. : 118-122

Informa Healthcare

Access to resources Recommend Favorite

Central functions of neuropeptide Y in mood and anxiety disorders

By Wu Gang Feder Adriana Wegener Gregers Bailey Christopher Saxena Shireen Charney Dennis Mathé Aleksander A

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. : 1317-1331

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of Comorbid Mood, Anxiety, and Substance Use Disorders

By Brady Kathleen Verduin Marcia

Substance Use & Misuse, Vol. 40, Iss. 13-14, 2005-12 ,pp. : 2021-2041

Informa Healthcare

Access to resources Recommend Favorite

The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-12 ,pp. : 451-458

Bentham Science Publishers

Access to resources Recommend Favorite